| Category | BioTech |
| Phone | 49-30-9489-4050 |
| Employees | |
| Founded | 2000 |
| TOTAL | $5.11M |
| VENTURE FUNDING TOTAL | $5.11M |
| Series C, 5/06 Aurelia Private Equity 3i Group BC Brandenburg Capital | $5.11M |
Combinature Biopharm is a drug discovery and development company, which uses a genomics and robotics driven technology platform to discover enzymes and the respective genes. The company’s products are used for biocatalysis applications and in-house in throughput combinatorial biosynthesis program aimed at generating natural compounds. The company has strategic partnerships with Aventis, Degussa, DSM, Novazymes, and PSF Biotech AG. Combinature Biopharm is based in Berlin, Germany. As of August 21, 2006, Combinature Biopharm is a subsidiary of MerLion Pharmaceuticals Pte Ltd.
